McMaster University
THE CAUSAL RELATIONSHIP BETWEEN CIRCULATING PAM LEVELS AND RISK OF TYPE 2 DIABETES: A MENDELIAN RANDOMIZATION STUDY
Abstract
dc:description.abstractBackground/Hypothesis: Research into the biological mechanisms of type 2 diabetes (T2D) have unveiled new genes and proteins associated with the disease. One of these discoveries was peptidylglycine α-amidating monooxygenase (PAM), in which loss of function alleles have been associated with increased T2D risk and its deficiency was shown to lower insulin secretion in-vivo. However, the question of whether PAM modulates insulin secretion in humans has gone unanswered. Using the genetic inference method 2-sample Mendelian randomization (MR), we hypothesized that decreased circulating PAM protein would increase T2D risk by lowering insulin secretion and causing increased post-prandial glucose levels. Methodology: We created PAM instrumental variables (IVs) from a meta-analysis of protein quantitative trait loci from European subsets of the UK Biobank (N=34,557) and the Prospective Urban and Rural Epidemiological Study (N=3,735). The PAM IVs were tested against single nucleotide polymorphisms associated with a total of 18 traits, including T2D from different populations, early onset T2D, glycated haemoglobin, and three blood glucose measurements of varying stratifications. Results: MR analyses confirmed that 1 SD decrease in genetically predicted PAM circulating levels was associated with increased T2D risk, both with adjustment for BMI (OR per 1 SD decrease PAM = 1.14; 95% CI, 1.11 to 1.16; P=7.64×10-25), and without (OR per 1 SD decrease PAM = 1.13; 95% CI, 1.10 to 1.15; P=1.84×10-31). FG showed consistent decrease of FG in response to PAM levels (mmol/L FG change per 1 SD decrease PAM = -0.014; 95% CI, -0.019 to -0.009; P=2.08×10-8) while post-prandial 2hGlu increased (mmol/L FG change per 1 SD decrease PAM = 0.057; 95% CI, 0.021 to 0.093; P=1.98×10-3). Conclusion: Using 2-sample MR, PAM deficiency was reconfirmed to increase T2D risk and newly found to increase postprandial glucose. Enhancement of circulating PAM level may be a promising therapeutic prospect in the solution of diabetes prevention and treatment.
Degree
thesis:*- Department dc:contributor.department
- Biochemistry and Biomedical Sciences
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Feiner, James
- Advisor dc:contributor.advisor
-
- Pigeyre, Marie
Subjects
dc:subject × 8Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Identifier URI
- https://doi.org/10.71548/16293